“Evaluating Effectiveness of Deferasirox Versus Deferoxamine in Improving Clinical Outcomes among Patients with Transfusion-Dependent Thalassemia: A Randomized Controlled Trial” (2025) Link Medical Journal, 3(2), pp. 1–12. doi:10.61919/e41dwh72.